Health and Care Research Wales Support & Delivery Service

A Message from Lord Pickles and Lord Blunkett, followed by Health and Care Research Wales Support & Delivery Service's best practice article

The ability to listen and learn from one another has always been vital in parliament, in business and in most aspects of daily life. But at this particular moment in time, as national and global events continue to reiterate, it is uncommonly crucial that we forge new channels of communication and reinforce existing ones. The following article from Health and Care Research Wales Support & Delivery Service is an attempt to do just that. We would welcome your thoughts on this or any other Parliamentary Review article.

Blunkett signature Rt Hon The Lord David Blunkett
Pickles signature Rt Hon The Lord Eric Pickles

www.healthandcareresearch.gov.wales

BEST PRACTICE REPRESENTATIVE 2019
THE PARLIAMENTARY REVIEW
Highlighting best practice
34 | LAUNCH DIAGNOSTICS
through privatisation, consolidation
and hospital mergers. This has led to
a unique competitive market with a
decrease in potential customers, and
an increase in suppliers to market.
Despite this, and the heavy financial
constraints on the NHS, we have
remained a trusted, reliable and
quality supplier of diagnostic tests and
equipment to the health system, and
we have achieved an excellent growth
rate over the last ten years.
This growth is reflected not only in our
turnover but also in our customer base,
staff and manufacturing partnerships.
We undertook a large-scale initiative
in 2013 with the aim of establishing a
business in France.
In the in-vitro medical diagnostics
market, France is ranked as second-
largest country with a turnover
of 1.8 billion euros. We started in
France with just one employee in
the field in 2017 but now have our
own operational subsidiary, Launch
Diagnostics France SAS, and a fully
dedicated team.
In 2018, the company exceeded the
two million euro mark, and we expect
this growth to continue into 2019
based on current projections. To
maintain this momentum with regard
to other European territories, we are
now prosperously trading in Ireland,
Belgium and Luxembourg.
Maintaining leadership in the
NHS despite challenges
The NHS is working under a heavily
restricted budget, which results in
a higher degree of selectivity on
their part for all supplies, including
those for diagnostics. To maintain
our position in the market and fulfil
their requirements, we continue to
provide high-quality products at an
affordableprice.
The quality of products in the market
is governed by external organisations
through many directives, guidelines and
quality standards for manufacturers
and suppliers alike. For example, all the
products we supply must be CE-marked
and, as medical regulations and ISO
accreditations become more stringent,
we will see our cost base rise.
As with every new challenge we have
encountered over the years, we intend
to approach these step by step, with
an open mind and a positive outlook.
Looking forward
2020 will mark our 30th anniversary,
and we are looking forward to this
important milestone to reflect on what
we have achieved so far as well as
what we would like to accomplish in
the future.
We want to maintain and develop
our level of expertise and excellence
within the diagnostics industry and
continue to provide high-quality tests
and equipment to enable optimum
patientcare.
Our personnel
are our most
valuable asset,
and we know
they are the
key to our
success
Launch Diagnostics
exhibiting some of the
equipment they supply
35HEALTH AND CARE RESEARCH WALES SUPPORT & DELIVERY SERVICE |
HEALTHCARE & PHARMACEUTICAL
Director Dr Nicola Williams
Offering new and emerging
treatment options to
patients in Wales
Health and Care Research Wales is funded and
overseen by the Welsh government’s research and
development division. It provides an infrastructure
to support and increase capacity in R&D, while managing
a range of funding schemes and the NHS R&D funding
allocation. To place Wales at the international forefront of
health and social care research, the support and delivery
service is an essential part of that infrastructure, enabling
the efficient set up and delivery of research studies in Wales.
DirectorDrNicolaWilliamselaborates.
The Cochrane name today is a byword for research quality and rigour worldwide.
Yet it was in the mining communities of 1950s South Wales that Archie Cochrane
first established his methods and principles, recruiting 25,000 people into a
range of studies, making the casual link between coal dust and disability. Wales’
profound contribution to better health and care in the UK and globally through
research since then is something we’re proud of and determined to build on.
In 2019, that growth is centred on development of a seamless, one-Wales research
support service for the three million people of Wales, working with industry and
research partners worldwide to give them faster access to more studies. Those
partners are tapping into continued research excellence in many specialties
across sites, bolstered by the Welsh government’s commitment to a world-class
researchinfrastructure.
FACTS ABOUT
HEALTH AND CARE RESEARCH
WALES SUPPORT AND DELIVERY
SERVICE
»Director: Dr Nicola Williams
»Founded in 2015
»Located in Wales
»Services: Research study set-up
and delivery support
»Serves all health and social care
researchers conducting studies
in Wales
»Covers a population of 3.1
million
Health and Care Research Wales
Support & Delivery Service
THE PARLIAMENTARY REVIEW
Highlighting best practice
THE PARLIAMENTARY REVIEW
Highlighting best practice
36 | HEALTH AND CARE RESEARCH WALES SUPPORT & DELIVERY SERVICE
Developing a service to
support research
Our response to the complexity
and challenge of efficient research
study set-up and delivery was the
2016 launch of the Health and
Care Research Wales and Support
and Delivery Service. Co-ordinated
at national level, it spans primary,
secondary and social care. It is
integrated across all ten NHS
organisations in Wales, including over
100 research-ready general practices.
That service is central to realising
a “One Wales” approach,
through three strategic aims: to
increase public access to research
opportunities; providing researchers
and industry colleagues with a
single-access streamlined service;
and attracting and deploying the
best people. Through shared values
and behaviours, our people are
helping open studies across more
sites for more people, increasing the
efficiency of study set-up and delivery
for industry and research partners
and building a strong, professional
research culture in Wales.
Making the most of Wales’
wealth of sites
The huge research potential of Wales’
fully integrated National Health
Service, touching on every aspect of
health and social care for three million
people, also presents challenges to
setting up sites for research studies.
From community hospitals and
doctors’ surgeries through to specialist
acute units, there is a need to connect
the right people with the right
researchopportunities.
In response, we entered a UK-wide
collaboration in 2018 that established
a single entry point for distributing
new commercial study opportunities
to NHS sites across all four nations.
Our simultaneous launch of a Welsh
national industry team to rapidly
co-ordinate responses to these
opportunities means that commercial
research organisations now have one
conversation that opens up the whole
of Wales to new studies.
Our national specialty leads, expert
clinical researchers who work with
potential local researchers, are key to
the process, providing a rapid insight
into the feasibility of delivery in Wales
and enabling quick, realistic responses
for industry. We’ve since expanded this
approach to non-commercial research,
opening studies beyond one site or
organisation where possible in a co-
ordinated way, always aiming to give
the greatest number of people across
Wales the opportunity to take part.
Making it easier to set up
With the right sites selected, there
comes the longstanding challenge of
opening a study as quickly as possible.
A decade of increasing regulatory
and legal requirements implemented
through disparate local approaches has
generated complexity that can delay a
study starting.
Multidisciplinary research
teams work together to
deliver studies
A “One Wales”
approach,
through three
strategic aims:
to increase
public access to
opportunities;
providing
researchers and
industry
colleagues with
a single-access
streamlined
service; and
attracting and
deploying the
best people
37HEALTH AND CARE RESEARCH WALES SUPPORT & DELIVERY SERVICE |
HEALTHCARE & PHARMACEUTICAL
Recognising this, we have collaborated
with UK colleagues to establish a
consistent, standardised approach to
sharing information between research
sponsor and sites and to simplify the
regulatory approvals process. In April
2019, we launched an integrated
approvals process in England and
Wales, bringing together staff that had
previously supported the ethical and
regulatory reviews of a study separately.
This will simplify the communication
between the regulatory bodies and the
researcher, leaving local sites to focus
on practical study set-up and recruiting
participants as quickly as possible.
At a local level, we know a significant
rate-limiting step to getting a
study set up can be agreeing the
contractual arrangements – so we
established a national “One cost,
one contract” service last year. This
provides an expert, single review that
is accepted by all participating sites
in Wales. Removing the need for
further negotiations, this has already
demonstrated benefits, bringing the
speed of contract negotiations in
secondary locations down to a matter
of days in some cases.
Ensuring successful study
delivery
Our “One Wales” approach has seen
ever increasing co-ordination and
oversight of delivery, which in recent
years is also helping to identify more
systemic issues that we can respond
to. Our proactive, national approach
means we have greater opportunity
to meet recruitment targets, on
time, with a fast escalation process
to rapidly spot and resolve study
performanceissues.
In 2016, we restructured our research
delivery workforce, which gave
researchers quicker access to the skilled
staff they needed. By incorporating local
research staff into a national support
and delivery service, we have developed
a networked, dedicated, skilled
workforce responsive to the research
need across Wales. There’s still more
to do here, with current programmes
focused on better understanding our
national skill mix, increasing the fluidity
of resource deployment and creating
clear professional career pathways
forresearch staff.
Our proactive,
national
approach means
we have greater
opportunity to
meet recruitment
targets, on time,
with a fast
escalation
process to
rapidly spot and
resolve study
performance
issues
Efficient study setup
enables more people to
participate in research
BEST PRACTICE REPRESENTATIVE 2019
THE PARLIAMENTARY REVIEW
Highlighting best practice
36 | HEALTH AND CARE RESEARCH WALES SUPPORT & DELIVERY SERVICE
Developing a service to
support research
Our response to the complexity
and challenge of efficient research
study set-up and delivery was the
2016 launch of the Health and
Care Research Wales and Support
and Delivery Service. Co-ordinated
at national level, it spans primary,
secondary and social care. It is
integrated across all ten NHS
organisations in Wales, including over
100 research-ready general practices.
That service is central to realising
a “One Wales” approach,
through three strategic aims: to
increase public access to research
opportunities; providing researchers
and industry colleagues with a
single-access streamlined service;
and attracting and deploying the
best people. Through shared values
and behaviours, our people are
helping open studies across more
sites for more people, increasing the
efficiency of study set-up and delivery
for industry and research partners
and building a strong, professional
research culture in Wales.
Making the most of Wales’
wealth of sites
The huge research potential of Wales’
fully integrated National Health
Service, touching on every aspect of
health and social care for three million
people, also presents challenges to
setting up sites for research studies.
From community hospitals and
doctors’ surgeries through to specialist
acute units, there is a need to connect
the right people with the right
researchopportunities.
In response, we entered a UK-wide
collaboration in 2018 that established
a single entry point for distributing
new commercial study opportunities
to NHS sites across all four nations.
Our simultaneous launch of a Welsh
national industry team to rapidly
co-ordinate responses to these
opportunities means that commercial
research organisations now have one
conversation that opens up the whole
of Wales to new studies.
Our national specialty leads, expert
clinical researchers who work with
potential local researchers, are key to
the process, providing a rapid insight
into the feasibility of delivery in Wales
and enabling quick, realistic responses
for industry. We’ve since expanded this
approach to non-commercial research,
opening studies beyond one site or
organisation where possible in a co-
ordinated way, always aiming to give
the greatest number of people across
Wales the opportunity to take part.
Making it easier to set up
With the right sites selected, there
comes the longstanding challenge of
opening a study as quickly as possible.
A decade of increasing regulatory
and legal requirements implemented
through disparate local approaches has
generated complexity that can delay a
study starting.
Multidisciplinary research
teams work together to
deliver studies
A “One Wales”
approach,
through three
strategic aims:
to increase
public access to
opportunities;
providing
researchers and
industry
colleagues with
a single-access
streamlined
service; and
attracting and
deploying the
best people
37HEALTH AND CARE RESEARCH WALES SUPPORT & DELIVERY SERVICE |
HEALTHCARE & PHARMACEUTICAL
Recognising this, we have collaborated
with UK colleagues to establish a
consistent, standardised approach to
sharing information between research
sponsor and sites and to simplify the
regulatory approvals process. In April
2019, we launched an integrated
approvals process in England and
Wales, bringing together staff that had
previously supported the ethical and
regulatory reviews of a study separately.
This will simplify the communication
between the regulatory bodies and the
researcher, leaving local sites to focus
on practical study set-up and recruiting
participants as quickly as possible.
At a local level, we know a significant
rate-limiting step to getting a
study set up can be agreeing the
contractual arrangements – so we
established a national “One cost,
one contract” service last year. This
provides an expert, single review that
is accepted by all participating sites
in Wales. Removing the need for
further negotiations, this has already
demonstrated benefits, bringing the
speed of contract negotiations in
secondary locations down to a matter
of days in some cases.
Ensuring successful study
delivery
Our “One Wales” approach has seen
ever increasing co-ordination and
oversight of delivery, which in recent
years is also helping to identify more
systemic issues that we can respond
to. Our proactive, national approach
means we have greater opportunity
to meet recruitment targets, on
time, with a fast escalation process
to rapidly spot and resolve study
performanceissues.
In 2016, we restructured our research
delivery workforce, which gave
researchers quicker access to the skilled
staff they needed. By incorporating local
research staff into a national support
and delivery service, we have developed
a networked, dedicated, skilled
workforce responsive to the research
need across Wales. There’s still more
to do here, with current programmes
focused on better understanding our
national skill mix, increasing the fluidity
of resource deployment and creating
clear professional career pathways
forresearch staff.
Our proactive,
national
approach means
we have greater
opportunity to
meet recruitment
targets, on time,
with a fast
escalation
process to
rapidly spot and
resolve study
performance
issues
Efficient study setup
enables more people to
participate in research

www.healthandcareresearch.gov.wales

This article was sponsored by Health and Care Research Wales Support & Delivery Service. The Parliamentary Review is wholly funded by the representatives who write for it. The publication in which this article originally appeared contained the following foreword from Rt Hon Michael Gove.

Rt Hon Michael Gove's Foreword For The Parliamentary Review

By Rt Hon Michael Gove

This year's Parliamentary Review comes at a momentous time for parliament, as we collectively determine the destiny of the United Kingdom. 

On October 31, the UK will leave the European Union. The successful implementation of this process is this government's number-one priority.

Three years after a historic referendum vote, we will deliver on the decisive mandate from the British people. Trust in our democracy depends on it. Until that final hour, we will work determinedly and diligently to negotiate a deal, one that abolishes the backstop and upholds the warm and close relationship we share with our friends, allies and neighbours in the EU. But in the event that the EU refuses to meet us at the table, we must be prepared to leave without a deal.

As the Chancellor of the Duchy of Lancaster, it is my job to lead on this government's approach, should that scenario happen. Preparing for Brexit is my department's driving mission. But while I am leading this turbocharged effort, the whole of government is committed to this endeavour.

Ministers across Whitehall are working together to ensure that every possibility is considered, every plan is scrutinised and every provision is made. A daily drumbeat of meetings means that we are holding departments accountable, so that preparations are completed on time.

The chancellor has confirmed that all necessary funding will be made available. And we have mobilised thecivil service, assigning 15,000 of our most talented civil servants to manage our exit from the EU.

We will make sure that on November 1, there is as little disruption to national life as possible. Our trade relationships will continue to thrive, thanks to agreements with countries around the world worth £70 billion. Our country will remain secure, thanks to nearly 1,000 new officers posted at our borders. And the 3.2 million EU nationals now living and working among us can remain confident, with absolute certainty, of their right to remain in the UK.

Above all, our goal is to be transparent. Soon, we will launch a public information campaign so that citizens, communities and businesses are ready and reassured about what will happen in the event of “no deal”.

In my first few weeks in this role, I have travelled to ports and tarmacs, borders and bridges, all across the UK –from the seaside of Dover to the rolling green hills of County Armagh. I have heard from business owners and border officials, farmers and hauliers. They are ready to put an end to uncertainty. And they are ready to embrace the opportunities ahead.

Our departure from the EU will be a once in a lifetime chance to chart a new course for the United Kingdom. Preparing for that new course will be a herculean effort. But this country has made astounding efforts before. We can do it again.
Rt Hon Michael Gove
Chancellor of the Duchy of Lancaster